SynthesisMedicine2018

Efficacy and safety of empagliflozin for type 2 diabetes mellitus: Meta-analysis of randomized controlled trials.

Yun-Jing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.